[Oral antiplatelet therapy in acute coronary syndromes: What do current guidelines say?].
Oral antiplatelet therapy has a pivotal role in the treatment of acute coronary syndromes (ACS). Recent advances in the field of oral antiplatelet agents have led to guideline updates and changed the clinical practice of treating patients with ACS. This review summarizes the up-to-date recommendations of current guidelines regarding the use of oral antiplatelet agents in the setting of ACS.
Sinan
S
Aydoğdu
D054058:Acute Coronary Syndrome / Q000188:drug therapy*; D000284:Administration, Oral; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D017410:Practice Guidelines as Topic
D010975:Platelet Aggregation Inhibitors